Areas of Expertise and Treatments
Chemotherapy uses anticancer medicines to destroy or control cancer cells and may be used alone or together with other cancer treatments.
High-dose chemotherapy uses intensive anticancer drug regimens in selected patients and requires careful monitoring and supportive care.
Immunotherapy helps the immune system recognise and attack cancer cells and may be used in selected solid tumors and blood cancers.
Targeted therapy uses medicines designed to act on specific molecular features of cancer cells and is selected according to tumor biology.
Medical treatment for breast cancer may include chemotherapy, targeted therapy, immunotherapy and hormonal treatment depending on tumor subtype and stage.
Triple-Negative Breast Cancer treatment may involve chemotherapy, immunotherapy and other systemic treatment approaches based on stage and clinical factors.
Lung cancer treatment may include chemotherapy, targeted medicines and immunotherapy depending on cancer type, stage and molecular findings.
Systemic treatment for gynaecological cancers may include chemotherapy, targeted therapy and immunotherapy as part of multidisciplinary care.
Genitourinary cancer care includes medical treatment for cancers affecting organs such as the kidneys, bladder and prostate.
Medical oncology treatment for head and neck cancers may include chemotherapy, targeted therapy or immunotherapy depending on disease characteristics.
Colorectal cancer treatment may include chemotherapy and targeted systemic treatment depending on stage and molecular profile.
Germ cell tumors are treated using systemic anticancer therapy tailored to the tumor type, stage and risk classification.
Lymphoma treatment is selected according to subtype and stage and may include chemotherapy, targeted therapy and immunotherapy.
Genetic testing can help identify inherited or tumor-specific changes that may influence screening, risk assessment or treatment planning.
Survivorship care focuses on follow-up, long-term treatment effects, recurrence monitoring and quality of life after active cancer treatment.